-
Sector Analysis
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Immunochemistry Analyzers Market Report Overview The immunochemistry analyzers market size was valued at $1.41 billion in 2023 and is expected to grow at a CAGR of more than 4% during 2023-2033. Immunochemistry analyzers are analytical laboratory equipment used to perform tests for infectious diagnostics, specific proteins, and therapeutic drugs. They are typically offered in modular increments, which can operate independently or simultaneously as a unit. Immunochemistry Analyzers Market Outlook, 2023-2033 ($ Billion) Buy the Full Report for More Insights into...
-
Sector Analysis
Polymerase Chain Reaction (PCR) Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
The PCR Market Report Overview The PCR market size was $700.3 million in 2023. Factors such as recent technological advances will drive the market growth at a CAGR of more than 5% from 2023 to 2033. Polymerase Chain Reaction (PCR) systems are used for nucleic acid amplification. They are commonly employed in investigations related to the diagnosis or prognosis of cancer or infectious diseases. The Polymerase chain reaction (PCR) is a method used to amplify short DNA or RNA sequences...
-
Sector Analysis
Point of Care (POC) Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Point of Care (POC) Analyzers Market Report Overview The POC analyzers market size was $162.2 million in 2023 and will grow at a CAGR of more than 6% during 2023-2033. Primarily, the adoption of POC PCR systems is increasing as they are generally viewed as being fast, effective, and reliable with modern technical functionalities, which will drive market growth during the forecast period. Point of Care Analyzers Market Outlook 2023-2033 ($ Million) Buy the Full Report for More Insights on...
-
Sector Analysis
Hematology Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Hematology Analyzers Market Report Overview The hematology analyzers market size was valued at $941.8 million in 2023. Factors such as the rising prevalence of diseases, including anemia, blood cancers, and disorders will primarily drive the hematology analyzers market growth. The hematology analyzers market will grow at a CAGR of more than 4% from 2023 to 2033. Hematology analyzers are used to perform tests related to blood and blood components. It is also used to identify and determine the morphology of...
-
Sector Analysis
Reproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Reproductive Hormones and Proteins Tests Market Report Overview The reproductive hormones and proteins tests market size was $119.1 million in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine functions and affect the health and behavior of both males and...
-
Product Insights
Cardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Sector Analysis
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Report Overview The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market size was $2.81 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic. However, if left untreated they can cause pelvic inflammatory disease (PID), which, in turn, can lead to additional complications such as infertility, ectopic...
-
Sector Analysis
In-Vitro Diagnostics (IVD) Market Size, Share and Trends Analysis by Region, Product and Segment Forecast to 2033
Accessing the in-depth insights from the ‘In Vitro Diagnostics’ report can help in: Gaining a valuable understanding of the current and future state of the market and allow businesses to make informed decisions about market entry, product development, and investments. Identifying competitors' capabilities to stay ahead in the market. Finding segments and getting an understanding of various stakeholders. Anticipating changes in demand and adjust business development strategies. Identifying potential regions and countries for growth opportunities. How is our ‘In Vitro Diagnostics’ report different from other...
-
Product Insights
Human Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...